scholarly journals Classification of complications of epilepsy surgery and invasive diagnostic procedures: A proposed protocol and feasibility study

Epilepsia ◽  
2021 ◽  
Author(s):  
Johan Bjellvi ◽  
J. Helen Cross ◽  
Maria Gogou ◽  
Mathilde Leclercq ◽  
Sylvain Rheims ◽  
...  
2007 ◽  
Vol 55 (22) ◽  
pp. 9128-9134 ◽  
Author(s):  
Tony Woodcock ◽  
Gerard Downey ◽  
J. Daniel Kelly ◽  
Colm O’Donnell

Biomedicines ◽  
2021 ◽  
Vol 9 (3) ◽  
pp. 310
Author(s):  
Yuta Tezuka ◽  
Yuto Yamazaki ◽  
Yasuhiro Nakamura ◽  
Hironobu Sasano ◽  
Fumitoshi Satoh

For the last seven decades, primary aldosteronism (PA) has been gradually recognized as a leading cause of secondary hypertension harboring increased risks of cardiovascular incidents compared to essential hypertension. Clinically, PA consists of two major subtypes, surgically curable and uncurable phenotypes, determined as unilateral or bilateral PA by adrenal venous sampling. In order to further optimize the treatment, surgery or medications, diagnostic procedures from screening to subtype differentiation is indispensable, while in the general clinical practice, the work-up rate is extremely low even in the patients with refractory hypertension because of the time-consuming and labor-intensive nature of the procedures. Therefore, a novel tool to simplify the diagnostic flow has been recently in enormous demand. In this review, we focus on recent progress in the following clinically important topics of PA: prevalence of PA and its subtypes, newly revealed histopathological classification of aldosterone-producing lesions, novel diagnostic biomarkers and prediction scores. More effective strategy to diagnose PA based on better understanding of its epidemiology and pathology should lead to early detection of PA and could decrease the cardiovascular and renal complications of the patients.


Cancers ◽  
2021 ◽  
Vol 13 (19) ◽  
pp. 4945
Author(s):  
Cristiane de Sá de Sá Ferreira-Facio ◽  
Vitor Botafogo ◽  
Patrícia Mello Ferrão ◽  
Maria Clara Canellas ◽  
Cristiane B. Milito ◽  
...  

Early diagnosis of pediatric cancer is key for adequate patient management and improved outcome. Although multiparameter flow cytometry (MFC) has proven of great utility in the diagnosis and classification of hematologic malignancies, its application to non-hematopoietic pediatric tumors remains limited. Here we designed and prospectively validated a new single eight-color antibody combination—solid tumor orientation tube, STOT—for diagnostic screening of pediatric cancer by MFC. A total of 476 samples (139 tumor mass, 138 bone marrow, 86 lymph node, 58 peripheral blood, and 55 other body fluid samples) from 296 patients with diagnostic suspicion of pediatric cancer were analyzed by MFC vs. conventional diagnostic procedures. STOT was designed after several design–test–evaluate–redesign cycles based on a large panel of monoclonal antibody combinations tested on 301 samples. In its final version, STOT consists of a single 8-color/12-marker antibody combination (CD99-CD8/numyogenin/CD4-EpCAM/CD56/GD2/smCD3-CD19/cyCD3-CD271/CD45). Prospective validation of STOT in 149 samples showed concordant results with the patient WHO/ICCC-3 diagnosis in 138/149 cases (92.6%). These included: 63/63 (100%) reactive/disease-free samples, 43/44 (98%) malignant and 4/4 (100%) benign non-hematopoietic tumors together with 28/38 (74%) leukemia/lymphoma cases; the only exception was Hodgkin lymphoma that required additional markers to be stained. In addition, STOT allowed accurate discrimination among the four most common subtypes of malignant CD45− CD56++ non-hematopoietic solid tumors: 13/13 (GD2++ numyogenin− CD271−/+ nuMyoD1− CD99− EpCAM−) neuroblastoma samples, 5/5 (GD2− numyogenin++ CD271++ nuMyoD1++ CD99−/+ EpCAM−) rhabdomyosarcomas, 2/2 (GD2−/+ numyogenin− CD271+ nuMyoD1− CD99+ EpCAM−) Ewing sarcoma family of tumors, and 7/7 (GD2− numyogenin− CD271+ nuMyoD1− CD99− EpCAM+) Wilms tumors. In summary, here we designed and validated a new standardized antibody combination and MFC assay for diagnostic screening of pediatric solid tumors that might contribute to fast and accurate diagnostic orientation and classification of pediatric cancer in routine clinical practice.


2019 ◽  
Vol 104 (12) ◽  
pp. 6129-6138 ◽  
Author(s):  
Mikkel Andreassen ◽  
Emma Ilett ◽  
Dominik Wiese ◽  
Emily P Slater ◽  
Marianne Klose ◽  
...  

Abstract Introduction Diagnosis and pathological classification of insulinomas are challenging. Aim To characterize localization of tumors, surgery outcomes, and histopathology in patients with insulinoma. Methods Patients with surgically resected sporadic insulinoma were included. Results Eighty patients were included. Seven had a malignant tumor. A total of 312 diagnostic examinations were performed: endoscopic ultrasonography (EUS; n = 59; sensitivity, 70%), MRI (n = 33; sensitivity, 58%), CT (n = 55; sensitivity, 47%), transabdominal ultrasonography (US; n = 45; sensitivity, 40%), somatostatin receptor imaging (n = 17; sensitivity, 29%), 18F-fluorodeoxyglucose positron emission tomography/CT (n = 1; negative), percutaneous transhepatic venous sampling (n = 10; sensitivity, 90%), arterial stimulation venous sampling (n = 20; sensitivity, 65%), and intraoperative US (n = 72; sensitivity, 89%). Fourteen tumors could not be visualized. Invasive methods were used in 7 of these 14 patients and localized the tumor in all cases. Median tumor size was 15 mm (range, 7 to 80 mm). Tumors with malignant vs benign behavior showed less staining for insulin (3 of 7 vs 66 of 73; P = 0.015) and for proinsulin (3 of 6 vs 58 of 59; P < 0.001). Staining for glucagon was seen in 2 of 6 malignant tumors and in no benign tumors (P < 0.001). Forty-three insulinomas stained negative for somatostatin receptor subtype 2a. Conclusion Localization of insulinomas requires many different diagnostic procedures. Most tumors can be localized by conventional imaging, including EUS. For nonvisible tumors, invasive methods may be a useful diagnostic tool. Malignant tumors showed reduced staining for insulin and proinsulin and increased staining for glucagon.


1982 ◽  
Vol 39 (12) ◽  
pp. 1725-1729 ◽  
Author(s):  
Michael L. Kent

Morphological, cultural, and biochemical characteristics of Pasteurella spp. and Vibrio spp. pathogenic to fishes are investigated. Vibrio anguillarum, V. ordalii, V. alginolyticus, V. parahaemolyticus, an unidentified Vibrio sp. (AN1K), Pasteurella piscicida, and P. multocida were cultured on API-20E multitube test strips (Analytab Products) and in Baumann's marine media with similar results. The API-20E Profile Index was not useful for classification of fish bacteria studied and, using the index. Vibrio sp. AN1K was misidentified as P. multocida. Bacteria studied were also grown on Marine Agar (Difco) and on blood agar at 25 and 37 °C. On blood agar at 37 °C some vibrios resembled pasteurellas as a result of pleomorphism and lack of motility. Simple diagnostic procedures for identifying Pasteurella spp. and Vibrio spp. associated with fishes using the API-20E with modifications are presented.Key words: Pasteurella, Vibrio, characteristics, Analytical Profile Index, fish pathology


1979 ◽  
Vol 2 (2) ◽  
pp. 56-62 ◽  
Author(s):  
Howard S. Adelman

As the diagnosis of learning disabilities has become widespread and commonplace, considerable debate has raged over the issue of labeling. Since the polemics have generated some confusion, it is important that professionals not lose sight of the major purposes and serious concerns related to diagnostic practices. In a two-part series, Adelman will (1) highlight why diagnostic procedures are necessary and why it is difficult to arrive at a valid diagnosis and (2) offer some perspectives on research and ethical considerations related to current LD diagnostic practices. In this first article, discussion of purposes and problems involved in diagnosing LD focuses on three topics: (a) how diagnosis relates to other assessment activity, (b) the objectives of diagnostic classification, and (c) specific conceptual concerns regarding the LD label.


2016 ◽  
Author(s):  
Sahar Ghavidel ◽  
Farhad Imani ◽  
Siavash Khallaghi ◽  
Eli Gibson ◽  
Amir Khojaste ◽  
...  

2007 ◽  
Vol 21 (10-11) ◽  
pp. 451-458 ◽  
Author(s):  
Lars Nørgaard ◽  
György Sölétormos ◽  
Niels Harrit ◽  
Morten Albrechtsen ◽  
Ole Olsen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document